Skip to Content

LPZ 15 ap (Lansoprazole delayed-release 15 mg)

Pill imprint LPZ 15 ap has been identified as Lansoprazole delayed-release 15 mg.

Lansoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; gerd; helicobacter pylori infection; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lansoprazole delayed-release
Imprint:
LPZ 15 ap
Strength:
15 mg
Color:
Blue & Pink
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Ajanta Pharma Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide